FSD Pharma Signs Definitive Agreement To Launch UNBUZZD, A Revolutionary Rapid Alcohol Detoxification Drink
Portfolio Pulse from Happy Mohamed
FSD Pharma Inc. (NASDAQ:HUGE) has signed an agreement with Celly Nutrition Inc. to launch UNBUZZD, a rapid alcohol detoxification drink. The launch will be led by former executives from Coca-Cola (NYSE:KO) and Celsius Holdings (NASDAQ:CELH). FSD Pharma will receive a 7% royalty on revenue from Celly Nutrition until a total of $250 million has been paid, after which the rate will be reduced to 3%. FSD Pharma has also been issued 100 million common shares in Celly Nutrition and an anti-dilution warrant.
August 04, 2023 | 11:01 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The involvement of a former Celsius Holdings executive in the launch of UNBUZZD could potentially have a positive impact on Celsius Holdings' reputation.
The involvement of a former Celsius Holdings executive in the launch of UNBUZZD could potentially boost Celsius Holdings' reputation, but it's unlikely to have a significant impact on its stock price.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 50
NEUTRAL IMPACT
The involvement of a former Coca-Cola executive in the launch of UNBUZZD could potentially have a positive impact on Coca-Cola's reputation.
The involvement of a former Coca-Cola executive in the launch of UNBUZZD could potentially boost Coca-Cola's reputation, but it's unlikely to have a significant impact on its stock price.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 50
POSITIVE IMPACT
FSD Pharma's partnership with Celly Nutrition and the launch of UNBUZZD could potentially increase its revenue and shareholder value.
The launch of UNBUZZD, led by experienced executives, could potentially increase FSD Pharma's revenue, especially with the 7% royalty agreement. The issuance of 100 million common shares and an anti-dilution warrant could also increase shareholder value.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100